XOMA Royalty (XOMA) Short term Debt (2011 - 2026)
XOMA Royalty's (XOMA) quarterly Short term Debt came in at $14.0 million in Q1 2026, up 2.31% year-on-year from $13.7 million in Q1 2025, and up 11.87% quarter-over-quarter from $12.5 million in Q4 2025.
XOMA Royalty (XOMA) Short term Debt (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed Short term Debt across 15 years of filings, most recently posting $14.0 million for Q1 2026.
- Short term Debt for Q1 2026 came in at $14.0 million, up 2.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.0 million (up 2.31% YoY), and the FY2025 annual result was $12.5 million, up 9.94% from the prior year.
- Short term Debt came in at $14.0 million for Q1 2026 at XOMA Royalty, up from $12.5 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $14.3 million in Q3 2025 to a low of $5.5 million in Q4 2023.
- The 4-year median for Short term Debt is $11.5 million (2024), against an average of $10.5 million.
- Across the five-year window, Short term Debt jumped 122.93% in 2025 and increased 2.31% in 2026, its largest moves.
- XOMA Royalty's Short term Debt stood at $5.5 million in 2023, then surged by 105.56% to $11.4 million in 2024, then grew by 9.94% to $12.5 million in 2025, then gained by 11.87% to $14.0 million in 2026.
- The last three Short term Debt figures came in at $14.0 million (Q1 2026), $12.5 million (Q4 2025), and $14.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.01 Mn |
| Dec 31, 2025 | 12.53 Mn |
| Sep 30, 2025 | 14.35 Mn |
| Jun 30, 2025 | 11.67 Mn |
| Mar 31, 2025 | 13.70 Mn |
| Dec 31, 2024 | 11.39 Mn |
| Sep 30, 2024 | 9.83 Mn |
| Jun 30, 2024 | 5.72 Mn |
| Mar 31, 2024 | 6.14 Mn |
| Dec 31, 2023 | 5.54 Mn |
| Mar 31, 2021 | 7.20 Mn |
| Dec 31, 2020 | 8.09 Mn |
| Sep 30, 2020 | 8.96 Mn |
| Jun 30, 2020 | 7.60 Mn |
| Mar 31, 2020 | 6.39 Mn |
| Dec 31, 2019 | 5.18 Mn |
| Sep 30, 2019 | 3.98 Mn |
| Jun 30, 2019 | 2.68 Mn |
| Mar 31, 2019 | 1.73 Mn |
| Dec 31, 2018 | 789,000.00 |